Neonatal Medicine

  • 제27권3호
  • /
  • Pages.99-104
  • /
  • 2020
  • /
  • 2287-9412(pISSN)
  • /
  • 2287-9803(eISSN)
대한신생아학회 (The Korean Society of Neonatology)
권호 표지
DOI QR코드

DOI QR Code

Comparison of Respiratory Outcomes between Less Invasive Surfactant Administration and the Intubation-Surfactant-Extubation Technique in Premature Infants with Respiratory Distress Syndrome

  • Kim, Hye Seon (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Hyun Ho (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Yang, Misun (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Han, Yea Seul (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Sung, Se In (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Ahn, So Yoon (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Chang, Yun Sil (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Park, Won Soon (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 투고 : 2020.04.20
  • 심사 : 2020.07.21
  • 발행 : 2020.08.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: To compare respiratory outcomes between less invasive surfactant administration (LISA) and the intubation-surfactant-extubation (INSURE) technique in premature infants with respiratory distress syndrome (RDS). Methods: We performed a retrospective medical chart review for 75 premature infants who were born at a gestational age (GA) of ≤34 weeks (between January 2017 and December 2019) and developed RDS after birth. Data on the demographic and outcome variables, including respiratory outcomes, were collected and compared between the infants who received LISA and those who received INSURE as a rescue therapy for RDS. Results: No signifcant differences in GA, birth weight, and other demographic characteristics were found between the LISA and INSURE groups (GA: 28.7 weeks vs. 28.8 weeks, P=0.449; birth weight: 1,236 g vs. 1,124 g, P=0.714). At the delivery room, although the infants showed no significant difference in positive pressure ventilation rate after birth, the LISA group showed a higher rate of continuous positive airway pressure application than the INSURE group. The infants in the LISA group presented a higher risk of requiring multiple doses of surfactant for RDS than the infants in the INSURE group (57% vs. 17.5%, P=0.001). However, the duration of invasive and/or noninvasive respiratory support and incidence of bronchopulmonary dysplasia showed no signifciant difference between the two groups. Conclusion: In the present study, no significant differences in the incidence of inhospital respiratory outcomes such as bronchopulmonary dysplasia were found between the LISA and INSURE groups. These results suggest that LISA can be an alternative therapeutic option for treating RDS to avoid intubation and mechanical ventilation in premature infants.

키워드

참고문헌

  1. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9. https://doi.org/10.1164/ajrccm.163.7.2011060
  2. Bancalari E, del Moral T. Bronchopulmonary dysplasia and surfactant. Biol Neonate 2001;80 Suppl 1:7-13. https://doi.org/10.1159/000047170
  3. Brew N, Hooper SB, Allison BJ, Wallace MJ, Harding R. Injury and repair in the very immature lung following brief mechanical ventilation. Am J Physiol Lung Cell Mol Physiol 2011;301:L917-26. https://doi.org/10.1152/ajplung.00207.2011
  4. Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2007;4:CD003063.
  5. Aguar M, Vento M, Dargaville PA. Minimally invasive surfactant therapy: an update. NeoReviews 2014;15:e275-85. https://doi.org/10.1542/neo.15-7-e275
  6. Isayama T, Iwami H, McDonald S, Beyene J. Association of noninvasive ventilation strategies with mortality and bronchopulmonary dysplasia among preterm infants: a systematic review and meta-analysis. JAMA 2016;316:611-24. https://doi.org/10.1001/jama.2016.10708
  7. Fischer HS, Buhrer C. Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a meta-analysis. Pediatrics 2013;132:e1351-60. https://doi.org/10.1542/peds.2013-1880
  8. Schmolzer GM, Kumar M, Pichler G, Aziz K, O'Reilly M, Cheung PY. Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis. BMJ 2013;347:f5980. https://doi.org/10.1136/bmj.f5980
  9. Aly H, Milner JD, Patel K, El-Mohandes AA. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants? Pediatrics 2004;114:697-702. https://doi.org/10.1542/peds.2003-0572-L
  10. Subramaniam P, Ho JJ, Davis PG. Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants. Cochrane Database Syst Rev 2016;6: CD001243.
  11. Finer N. To intubate or not, that is the question: continuous positive airway pressure versus surfactant and extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2006;91:F392-4. https://doi.org/10.1136/adc.2006.099754
  12. Berneau P, Nguyen Phuc Thu T, Pladys P, Beuchee A. Impact of surfactant administration through a thin catheter in the delivery room: a quality control chart analysis coupled with a propensity score matched cohort study in preterm infants. PLoS One 2018;13:e0208252. https://doi.org/10.1371/journal.pone.0208252
  13. More K, Sakhuja P, Shah PS. Minimally invasive surfactant administration in preterm infants: a meta-narrative review. JAMA Pediatr 2014;168:901-8. https://doi.org/10.1001/jamapediatrics.2014.1148
  14. Herting E. Less invasive surfactant administration (LISA): ways to deliver surfactant in spontaneously breathing infants. Early Hum Dev 2013;89:875-80. https://doi.org/10.1016/j.earlhumdev.2013.08.023
  15. Halim A, Shirazi H, Riaz S, Gul SS, Ali W. Less invasive surfactant administration in preterm infants with respiratory distress syndrome. J Coll Physicians Surg Pak 2019;29:226-330. https://doi.org/10.29271/jcpsp.2019.03.226
  16. Gregory KE, Deforge CE, Natale KM, Phillips M, Van Marter LJ. Necrotizing enterocolitis in the premature infant: neonatal nursing assessment, disease pathogenesis, and clinical presentation. Adv Neonatal Care 2011;11:155-64. https://doi.org/10.1097/anc.0b013e31821baaf4
  17. Roggini M, Pepino D, D'Avanzo M, Andreoli GM, Ceccanti S, Capocaccia P. Respiratory distress in newborn: evaluation of chest X-rays. Minerva Pediatr 2010;62:217-9.
  18. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001;2:CD000510.
  19. Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics 1999;103:E24. https://doi.org/10.1542/peds.103.2.e24
  20. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrom K, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med 1994;331:1051-5. https://doi.org/10.1056/NEJM199410203311603
  21. Dargaville PA, Aiyappan A, Cornelius A, Williams C, De Paoli AG. Preliminary evaluation of a new technique of minimally invasive surfactant therapy. Arch Dis Child Fetal Neonatal Ed 2011;96:F243-8. https://doi.org/10.1136/adc.2010.192518
  22. Yang G, Hei M, Xue Z, Zhao Y, Zhang X, Wang C. Effects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome in premature infants aged 32 to 36 weeks. Medicine (Baltimore) 2020;99:e19216. https://doi.org/10.1097/md.0000000000019216
  23. Kribs A, Hartel C, Kattner E, Vochem M, Kuster H, Moller J, et al. Surfactant without intubation in preterm infants with respiratory distress: first multi-center data. Klin Padiatr 2010;222:13-7. https://doi.org/10.1055/s-0029-1241867
  24. Herting E, Hartel C, Gopel W. Less invasive surfactant administration (LISA): chances and limitations. Arch Dis Child Fetal Neonatal Ed 2019;104:F655-9. https://doi.org/10.1136/archdischild-2018-316557
  25. Niemarkt HJ, Kuypers E, Jellema R, Ophelders D, Hutten M, Nikiforou M, et al. Effects of less-invasive surfactant administration on oxygenation, pulmonary surfactant distribution, and lung compliance in spontaneously breathing preterm lambs. Pediatr Res 2014;76:166-70. https://doi.org/10.1038/pr.2014.66
  26. Hartel C, Paul P, Hanke K, Humberg A, Kribs A, Mehler K, et al. Less invasive surfactant administration and complications of preterm birth. Sci Rep 2018;8:8333. https://doi.org/10.1038/s41598-018-26437-x

피인용 문헌

  1. Comparison of Respiratory Outcome between the Surfactant without Endotracheal Tube Intubation and the Intubation-Surfactant-Extubation Techniques in Extremely Low Gestational Age Neonates with Respira vol.32, pp.3, 2020, https://doi.org/10.14734/pn.2021.32.3.125